Chief Executive Officer
Jamie Macdonald is Chief Executive Officer of PAREXEL. A seasoned leader of the clinical research industry, Mr. Macdonald holds nearly 25 years of leadership experience with leading global biopharmaceutical services companies.
Prior to joining PAREXEL, Mr. Macdonald led INC Research, now known as Syneos Health, for several years first as CEO and later as Vice Chairman. As CEO, he was responsible for all aspects of INC’s business, performance and strategy. During his time at INC Research, Mr. Macdonald led the Company to industry-leading growth and margins, delivered strong operational and market performance, and undertook a successful Initial Public Offering in 2014.
Mr. Macdonald also served as INC’s Chief Operating Officer, and previously held several leadership positions in the biopharmaceutical services industry, including Senior Vice President and Head of Global Project Management at Quintiles, now known as IQVIA. Prior to this time, he held various senior operational and finance roles at Quintiles. He also served as Chairman of the Association of Clinical Research Organizations (ACRO) Board of Directors in 2015.
Mr. Macdonald began his career in the pharmaceutical industry with Syntex Corporation (acquired by Roche Holdings, Inc.). A native of Scotland, he holds a B.A. in Economics from Heriot-Watt University in Edinburgh, Scotland and is a qualified Chartered Management Accountant (ACMA).